Determination of the thermodynamic dissociation constant of capecitabine using spectrophotometric and potentiometric titration data

被引:16
作者
Meloun, Milan [1 ]
Ferencikova, Zuzana [1 ]
Vrana, Ales [2 ]
机构
[1] Univ Pardubice, Dept Analyt Chem, CZ-53210 Pardubice, Czech Republic
[2] TEVA Pharmaceut Sro, CZ-74770 Opava, Czech Republic
关键词
Spectrophotometric titration; Potentiometric titration; Dissociation constant; Capecitabine; SPECFIT; SQUAD; ESAB2M; HYPERQUAD; SQUARES NONLINEAR-REGRESSION; MULTIWAVELENGTH SPECTROSCOPIC DATA; EQUILIBRIUM-CONSTANTS; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; CANCER-PATIENTS; METABOLITES; PHARMACOKINETICS; PROGRAMS;
D O I
10.1016/j.jct.2011.01.012
中图分类号
O414.1 [热力学];
学科分类号
摘要
Capecitabine has been studied by a combined potentiometric and spectrophotometric titration at T = (298.15, 310.15) K at different ionic strengths. The thermodynamic dissociation constant was estimated by non-linear regression of (pK(a), I) data: pK(a)(T) = 8.97(1) at T = 298.15 K and pK(a)(T) = 8.74(0) at T = 310.15 K, where the figure in the brackets is the standard deviation in last significant digits. Thermodynamic parameters Delta H degrees/kJ.mol(-1) and Delta S degrees/J.K-1.mol(-1) have been determined from the temperature variation of thermodynamic dissociation constants. The value of enthalpy Delta H degrees = 33.9 kJ.mol(-1) shows the dissociation process is endothermic and the value of entropy Delta S degrees = -51.9J.K-1.mol(-1) indicates that the dissociation is not a spontaneous process. (c) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:930 / 937
页数:8
相关论文
共 32 条
[21]  
Reigner B, 1998, CLIN CANCER RES, V4, P941
[22]  
RIGANO C, 1984, ANN CHIM-ROME, V74, P532
[23]   Simultaneous determination of capecitabine and its metabolite 5-fluorouracil by column switching and liquid chromatographic/tandem mass spectrometry [J].
Siethoff, C ;
Orth, M ;
Ortling, A ;
Brendel, E ;
Wagner-Redeker, W .
JOURNAL OF MASS SPECTROMETRY, 2004, 39 (08) :884-889
[24]  
*SPECTR SOFTW ASS, 2004, SPECFIT32 SPECTR SOF
[25]  
*TRILOBYTE STAT SO, ADSTAT 1 25 2 0 3 0
[26]   Rational development of capecitabine [J].
Venturini, M .
EUROPEAN JOURNAL OF CANCER, 2002, 38 :S3-S9
[27]   Capecitabine - A review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer [J].
Wagstaff, AJ ;
Ibbotson, T ;
Goa, KL .
DRUGS, 2003, 63 (02) :217-236
[28]   Liquid chromatography-mass spectrometry method for the analysis of the anti-cancer agent capecitabine and its nucleoside metabolites in human plasma [J].
Xu, Y ;
Grem, JL .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 783 (01) :273-285
[29]  
Zekany L., 1985, Computational Method for Determination of FormationConstants, P291, DOI 10.1007/978-1-4684-4934-1_8
[30]   Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection [J].
Zufía, L ;
Aldaz, A ;
Giráldez, J .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 809 (01) :51-58